188 related articles for article (PubMed ID: 27034887)
21. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
[TBL] [Abstract][Full Text] [Related]
22. Altered protein expression pattern in skin fibroblasts from parkin-mutant early-onset Parkinson's disease patients.
Lippolis R; Siciliano RA; Pacelli C; Ferretta A; Mazzeo MF; Scacco S; Papa F; Gaballo A; Dell'Aquila C; De Mari M; Papa S; Cocco T
Biochim Biophys Acta; 2015 Sep; 1852(9):1960-70. PubMed ID: 26096686
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
24. Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism.
Pacelli C; Rotundo G; Lecce L; Menga M; Bidollari E; Scrima R; Cela O; Piccoli C; Cocco T; Vescovi AL; Mazzoccoli G; Rosati J; Capitanio N
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195749
[TBL] [Abstract][Full Text] [Related]
25. Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease.
Shiba-Fukushima K; Ishikawa KI; Inoshita T; Izawa N; Takanashi M; Sato S; Onodera O; Akamatsu W; Okano H; Imai Y; Hattori N
Hum Mol Genet; 2017 Aug; 26(16):3172-3185. PubMed ID: 28541509
[TBL] [Abstract][Full Text] [Related]
26. Regulation of ER-mitochondria contacts by Parkin via Mfn2.
Basso V; Marchesan E; Peggion C; Chakraborty J; von Stockum S; Giacomello M; Ottolini D; Debattisti V; Caicci F; Tasca E; Pegoraro V; Angelini C; Antonini A; Bertoli A; Brini M; Ziviani E
Pharmacol Res; 2018 Dec; 138():43-56. PubMed ID: 30219582
[TBL] [Abstract][Full Text] [Related]
27. The mitochondrial kinase PINK1: functions beyond mitophagy.
Voigt A; Berlemann LA; Winklhofer KF
J Neurochem; 2016 Oct; 139 Suppl 1():232-239. PubMed ID: 27251035
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin phosphorylation in Parkinson's disease: Implications for pathogenesis and treatment.
Chin LS; Li L
Transl Neurodegener; 2016; 5():1. PubMed ID: 26740872
[TBL] [Abstract][Full Text] [Related]
29. Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson's Disease.
Nardin A; Schrepfer E; Ziviani E
Curr Neuropharmacol; 2016; 14(3):250-9. PubMed ID: 26517048
[TBL] [Abstract][Full Text] [Related]
30. Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.
Smith GA; Jansson J; Rocha EM; Osborn T; Hallett PJ; Isacson O
Mol Neurobiol; 2016 Oct; 53(8):5161-77. PubMed ID: 26399642
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol Modulation of Protein Expression in
Vergara D; Gaballo A; Signorile A; Ferretta A; Tanzarella P; Pacelli C; Di Paola M; Cocco T; Maffia M
Oxid Med Cell Longev; 2017; 2017():2198243. PubMed ID: 29138676
[TBL] [Abstract][Full Text] [Related]
32. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy.
Van Laar VS; Roy N; Liu A; Rajprohat S; Arnold B; Dukes AA; Holbein CD; Berman SB
Neurobiol Dis; 2015 Feb; 74():180-93. PubMed ID: 25478815
[TBL] [Abstract][Full Text] [Related]
33. Protective role of Parkin in skeletal muscle contractile and mitochondrial function.
Gouspillou G; Godin R; Piquereau J; Picard M; Mofarrahi M; Mathew J; Purves-Smith FM; Sgarioto N; Hepple RT; Burelle Y; Hussain SNA
J Physiol; 2018 Jul; 596(13):2565-2579. PubMed ID: 29682760
[TBL] [Abstract][Full Text] [Related]
34. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair.
Rothfuss O; Fischer H; Hasegawa T; Maisel M; Leitner P; Miesel F; Sharma M; Bornemann A; Berg D; Gasser T; Patenge N
Hum Mol Genet; 2009 Oct; 18(20):3832-50. PubMed ID: 19617636
[TBL] [Abstract][Full Text] [Related]
35. Parkin and mitochondrial quality control: toward assembling the puzzle.
Winklhofer KF
Trends Cell Biol; 2014 Jun; 24(6):332-41. PubMed ID: 24485851
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
37. The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson's disease.
Yi W; MacDougall EJ; Tang MY; Krahn AI; Gan-Or Z; Trempe JF; Fon EA
Hum Mol Genet; 2019 Sep; 28(17):2811-2825. PubMed ID: 30994895
[TBL] [Abstract][Full Text] [Related]
38. ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons.
Joselin AP; Hewitt SJ; Callaghan SM; Kim RH; Chung YH; Mak TW; Shen J; Slack RS; Park DS
Hum Mol Genet; 2012 Nov; 21(22):4888-903. PubMed ID: 22872702
[TBL] [Abstract][Full Text] [Related]
39. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
[TBL] [Abstract][Full Text] [Related]
40. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
